An independent guide to cash-pay care. Every price is dated and sourced.

How we check

Medical weight loss in New York City

In New York City, medical weight loss runs through hospital programs such as NYU Langone and Weill Cornell, primary care, and online prescribers. Paying the drug makers directly, a New Yorker spends $149 to $449 a month on a brand GLP-1, depending on the product [1][2]. CDC PLACES estimates that 25.1% of the city's adults had obesity in 2023 [3].

Medical review: pending. A licensed clinician has not yet reviewed this page.

Medical weight loss is a clinician-supervised program that can combine prescription medication, nutrition and activity changes, and, for some patients, surgery.

Adults with obesity, NYC
25.1% (CDC PLACES, 2023) [3]
Highest borough rate
Bronx 33.5%; Manhattan lowest at 19.2% [4]
Diagnosed diabetes, NYC
11.9% of adults [3]
NY Medicaid GLP-1s for obesity
Not among the 13 covering states in KFF's Jan 2026 count [5]
Lowest brand cash price
Wegovy pill 1.5 mg, $149/month (checked Oct 17 2026) [2]

A citywide average that hides a 14-point borough gap

The citywide obesity estimate of 25.1% blends very different places. CDC PLACES puts the Bronx at 33.5% and Staten Island (Richmond County) at 30.3%, while Brooklyn is 25.1%, Queens 24.0% and Manhattan 19.2% [4]. Diagnosed diabetes follows a similar pattern: 16.1% in the Bronx and 14.3% in Queens against 8.9% in Manhattan [4].

That spread matters for cost. A Bronx or Queens resident with type 2 diabetes may get a diabetes drug through insurance, while a Manhattan resident using a GLP-1 only for weight often pays cash. Our medical weight loss guide explains the two paths.

The listing in this slot is paid and marked as such. Payment does not change what we write, and it is not an endorsement. See how we make money.

Hospital-based programs in the city

Two academic programs publish what they offer. We list them as facts, not rankings:

Neither program page lists a self-pay price. Ask whether visits are billed to insurance and whether medication is a separate pharmacy charge. Mount Sinai and NewYork-Presbyterian are other health systems in the city; we did not confirm a weight program page for either.

What the drug makers charge New Yorkers

Brand GLP-1 cash prices from the makers, as listed Oct 17 2026
Product and sellerPrice per monthSource
Zepbound vial or KwikPen from LillyDirect$299 at 2.5 mg, up to $449 at 7.5 to 15 mg if refilled within 45 days[1]
Wegovy pen from NovoCare$349; newcomers pay $199 for the first two fills at 0.25/0.5 mg[2]
Wegovy pill from NovoCare$149 at 1.5 mg, $299 at 9 and 25 mg[2]
Foundayo pill from LillyDirect$149 to $299 depending on dose[8]
Only the medicine is priced here. Manhattan and borough clinics bill visits, labs and needles on their own. Full breakdown: GLP-1 cost page. Tirzepatide-specific detail: tirzepatide in NYC.

Medicaid, Medicare and employer plans in New York

New York was missing from KFF's January 2026 list of 13 state Medicaid programs that cover GLP-1s for obesity [5]. Diabetes coverage is a separate question for your plan. Since July 1, 2026, Part D enrollees who meet the BMI rules can get Wegovy, Foundayo or the Zepbound KwikPen for weight management through the temporary GLP-1 Bridge at $50 a month [9][10]. Our Medicare GLP-1 page has the details.

Clinic, hospital program or online?

  • A hospital program fits someone who wants in-person monitoring, has several conditions, or may end up considering surgery.
  • An online program may cost less per visit. Look up the prescriber, the pharmacy and any FDA letter before paying; the online GLP-1 program comparison and FDA warning letter tracker help.
  • Compounded semaglutide or tirzepatide sold in the city has no FDA approval, and FDA does not review compounded drugs for safety, effectiveness or quality before they reach patients [11].

Read the label first

Wegovy and Zepbound are off limits for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2. Severe stomach pain that does not let up can mean pancreatitis: stop and get care. Allergic reactions need prompt attention, low blood sugar is more likely alongside insulin or a sulfonylurea, and the labels say to stop once a pregnancy is recognized [12][13]. For an emergency, call 911.

Looking elsewhere in the region? See Long Island, New Jersey and Philadelphia, or use the clinic finder checklist.

Questions people ask

Which NYC borough has the highest adult obesity rate?

The Bronx, at 33.5% in CDC PLACES 2023 estimates. Manhattan is lowest at 19.2%, and the citywide figure is 25.1% [3][4].

Does New York Medicaid cover Wegovy or Zepbound for weight loss?

New York was not among the 13 state Medicaid programs KFF counted as covering GLP-1s for obesity in January 2026 [5]. Ask your plan separately about coverage for type 2 diabetes.

What is the lowest brand GLP-1 cash price for a New Yorker?

On Oct 17 2026 it was $149 a month for the 1.5 mg Wegovy pill through NovoCare [2]; Foundayo's starting dose was also $149 through LillyDirect [8].

Do NYU Langone and Weill Cornell prescribe weight loss drugs?

Yes. NYU Langone says its Weight Management Program prescribes weight loss medication [6], and Weill Cornell lists medications among its services at 1305 York Avenue [7]. Neither posts a cash price.

How do New York Medicare members get a GLP-1 for weight?

Through the Medicare GLP-1 Bridge, open July 1 2026 to Dec 31 2027: eligible Part D enrollees who meet the BMI criteria pay $50 a month for Wegovy, Foundayo or the Zepbound KwikPen [9][10].

How common is diabetes in the Bronx compared with Manhattan?

CDC PLACES estimates diagnosed diabetes at 16.1% of Bronx adults and 8.9% of Manhattan adults, against 11.9% citywide [3][4].

Sources

13 cited
  1. Zepbound self-pay pricing. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
  2. Wegovy self-pay offer. Novo Nordisk (NovoCare Pharmacy), Oct 17, 2026.
  3. PLACES: Place Data, New York city (2025 release, BRFSS 2023). CDC, 2023.
  4. PLACES: County Data, New York City boroughs (2025 release, BRFSS 2023). CDC, 2023.
  5. Medicaid Coverage of and Spending on GLP-1s. KFF, Jan 16, 2026.
  6. Weight Management Program. NYU Langone Health, Oct 17, 2026.
  7. Comprehensive Weight Control Center. Weill Cornell Medicine, Oct 17, 2026.
  8. Foundayo self-pay pricing. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
  9. Weight loss drugs coverage. Medicare.gov (CMS), Oct 17, 2026.
  10. Medicare GLP-1 Bridge: information for pharmacies. Centers for Medicare & Medicaid Services, Oct 17, 2026.
  11. FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration, Oct 1, 2026.
  12. Zepbound prescribing information (217806s050). U.S. Food and Drug Administration, Apr 2026.
  13. Wegovy label (injection and tablets). DailyMed, National Library of Medicine, Jun 2026.

This page is general information, not medical advice. Talk with a licensed clinician about your own care.

Compare GLP-1 costs